However, this procedure is often challenging for specific groups of patients, including those suffering from type 2 diabetes mellitus (T2DM) and on insulin or intensive oral hypoglycemic therapy due to the increased risk of hypoglycemia after prolonged fasting. This evidence concerns the gene INS and type 2 diabetes mellitus.